Boston University Medical Center Leadership Program in Vascular Medicine
Boston University Medical Center Leadership Program in Vascular Medicine
批准号:
8527821
负责人:
Robert Thomas Eberhardt
金额:
$64.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-08 至 2015-06-30
关键词:
Academic Medical CentersBlood VesselsBostonCaringClinicalClinical TrialsCompetenceDisciplineDiseaseEducational CurriculumElementsEnsureEnvironmentEvaluationFosteringFundingFutureGoalsGrowthIndividualInvestigationKnowledgeLeadershipMaster&aposs DegreeMedicineMentorsOutcomePhysiciansPositioning AttributeProcessPublic Health SchoolsPublicationsResearchResearch DesignResearch PersonnelResearch Project GrantsResearch TrainingResourcesRotationScientistSpecialistTrainingUnited StatesUniversitiesVascular Diseasesabstractingcareerdesignexperienceinsightmeetingsnext generationprogramsskillssuccesssymposium
中文摘要
描述(由申请人提供):
不断发展的血管医学学科包括评估和管理一组多样化但普遍存在的疾病,其中许多疾病表示严重的结局。我们赞同这样一个原则,即美国没有足够的训练有素的专家来满足这一重要领域日益增长的需求。为了促进未来血管医学专家的成长,我们赞赏这一举措,以培养新的个人在临床血管相关研究的进行,从而作为下一代的学术领袖。波士顿大学血管医学领导计划将特别适合于培训医生从事血管医学学术生涯的目标。全面的临床课程利用多学科方法的优势(包括轮换,血管实验室暴露和教学法),旨在确保学员获得护理血管疾病谱所需的知识和临床经验。临床计划分为两个部分;一个是为一般血管医学培训设计的,另一个是为血管内专家定制的。研究部分将确保这些临床医生发展进行独立临床调查的技能和能力。研究培训的各个要素包括研讨会和会议的教学计划,在公共卫生的波士顿大学学院硕士学位课程的完成,以及监督的研究项目。该指导研究项目将在血管相关领域资深且经验丰富的研究人员的指导下进行。我们相信,波士顿大学医学中心是一个优秀而丰富的环境,可以培养未来的血管医学临床科学家,借鉴该领域许多知名和杰出的研究人员和项目的优势。我们利用我们共享的设施和资源,整合了这一方法。我们打算我们的计划,以促进洞察研究过程的所有步骤,从研究设计和资金,分析和出版。在该计划完成后,我们希望受训者能够展示在血管疾病护理的临床方面的专业知识,并能够很好地进行独立资助的血管研究,这两个属性被认为是该计划成功的关键。(End摘要)
英文摘要
DESCRIPTION (provided by applicant):
The evolving discipline of vascular medicine encompasses the evaluation and management of a diverse, yet prevalent, group of disorders, many of which denote a serious outcome. We endorse the principle that there are insufficient trained specialists in the United States to meet the growing demands of this important field.To foster the growth of future Vascular Medicine Specialists, we appreciate this initiative to train new individuals in the conduct of clinical vascular-related research and thus serve as the next generation of academic leaders. The Boston University Leadership Program in Vascular Medicine will be particularly well suited to the goal of training physicians to pursue an academic career in vascular medicine. The well rounded clinical curriculum utilizes the strengths of a multi-disciplinary approach (including rotations, vascular lab exposures, and didactics), designed to assure that trainees acquire the knowledge and clinical experience required to care for the spectrum of vascular disorders. The clinical program is sub-divided into two tracts; one designed for general vascular medicine training, and the other tailored towards the endovascular specialist. The research component will ensure that these clinicians develop the skills and competence to conduct independent clinical investigations. Individual elements of the research training include a didactic program of seminars and conferences, completion of a Masters Degree Program at the Boston University School of Public Health, and a supervised research project. This mentored research project will be conducted under the guidance of a senior and highly experienced researcher in a vascular related field. We believe that Boston University Medical Center serves as an excellent and rich environment to allow the training of future clinical scientists in vascular medicine, drawing on the strengths of many established and prominent investigators and programs in the field. We have integrated this approach, making use of our shared facilities and resources. We intend our program to promote insight into all steps of the research process, ranging from study design and funding to analysis and publication. Upon completion of the program we expect the trainee to demonstrate expertise in the clinical aspects of vascular disease care, and be well positioned to conduct independently funded vascular investigations, both attributes considered essential to the success of this program. (End of Abstract)
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/jaha.113.000136
发表时间:
2013-10-23
期刊:
Journal of the American Heart Association
影响因子:
5.4
作者:
[Cove CL, Hylek EM]
通讯作者:
Hylek EM
DOI:
10.2174/15701611113119990014
发表时间:
2015
期刊:
Current vascular pharmacology
影响因子:
4.5
作者:
[Hamburg NM, Leeper NJ]
通讯作者:
Leeper NJ
DOI:
10.1016/j.atherosclerosis.2016.01.043
发表时间:
2016-04
期刊:
Atherosclerosis
影响因子:
5.3
作者:
[Fetterman JL, Holbrook M, Flint N, Feng B, Bretón-Romero R, Linder EA, Berk BD, Duess MA, Farb MG, Gokce N, Shirihai OS, Hamburg NM, Vita JA]
通讯作者:
Vita JA
DOI:
10.1016/j.ahj.2016.08.017
发表时间:
2017-03
期刊:
American heart journal
影响因子:
4.8
作者:
[Fanola CL, Mooney D, Cowan AJ, Ko D, Sisson EK, Henault LE, Tripodis Y, Hylek EM]
通讯作者:
Hylek EM
Biomarkers in lone atrial fibrillation - an additional 'fine tuning' of risk?
孤立性心房颤动的生物标志物——风险的额外“微调”?
DOI:
10.2174/1381612820666140825131744
发表时间:
2015
期刊:
Current pharmaceutical design
影响因子:
3.1
作者:
[Ko,Darae, Magnani,JaredW, Hylek,ElaineM]
通讯作者:
Hylek,ElaineM
共 8 条
海外基金